Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334,352,960
-
Total 13F shares
-
157,911,036
-
Share change
-
-5,218,764
-
Total reported value
-
$3,881,960,135
-
Put/Call ratio
-
80%
-
Price per share
-
$24.66
-
Number of holders
-
236
-
Value change
-
-$128,206,957
-
Number of buys
-
113
-
Number of sells
-
108
Institutional Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q3 2021
As of 30 Sep 2021 IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) had 236 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 157,911,036 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, ARK Investment Management LLC, PERCEPTIVE ADVISORS LLC, WELLINGTON MANAGEMENT GROUP LLP, Avoro Capital Advisors LLC, BlackRock Inc., ORBIMED ADVISORS LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., and FRANKLIN RESOURCES INC.
This table shows 238 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.